The path to potential approval for bluebird bio’s lovo-cel has become slightly smoother as the FDA has confirmed it will not be holding an advisory committee meeting before making a decision on the ...
As an FDA decision draws closer on bluebird bio’s sickle cell disease gene therapy, the company has lined up a potential sale of a priority review voucher (PRV). The agreement, worth $103 million, ...
Two voice actors are leading a class-action lawsuit against AI voiceover company Lovo for using recordings of them to create a bot that replicates their voices — and competes with them for work. Paul ...
Defendant Lovo has moved to dismiss an amended complaint alleging that the voice actor Plaintiffs’ voices were unlawfully cloned by Defendant Lovo’s AI Voice Generator. Plaintiffs allege that Lovo’s ...
Voice Actors Can Make Thousands of Dollars Simply by Submitting a 15-Minute Voice Sample BERKELEY, CA / ACCESSWIRE / June 2, 2021 / LOVO, an AI voice-over platform for education, marketing, ...
District court denies in part and grants in part AI startup’s motion to dismiss claims by voice actors involving creation and use of AI-generated voice clones, allowing breach of contract and right of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback